Fibroblast growth factor 23: a biomarker of fibrosis and prognosis in heart failure with preserved ejection fraction

AIMS: Besides regulating calcium‐phosphate metabolism, fibroblast growth factor 23 (FGF‐23) has been associated with incident heart failure (HF) and left ventricular hypertrophy. However, data about FGF‐23 in HF and preserved ejection fraction (HFpEF) remain limited. The aim of this study was to ass...

Descripción completa

Detalles Bibliográficos
Autores principales: Roy, Clotilde, Lejeune, Sibille, Slimani, Alisson, de Meester, Christophe, Ahn AS, Sylvie A., Rousseau, Michel F., Mihaela, Amzulescu, Ginion, Audrey, Ferracin, Benjamin, Pasquet, Agnès, Vancraeynest, David, Beauloye, Christophe, Vanoverschelde, Jean‐Louis, Horman, Sandrine, Gruson, Damien, Gerber, Bernhard L., Pouleur, Anne‐Catherine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7524237/
https://www.ncbi.nlm.nih.gov/pubmed/32578967
http://dx.doi.org/10.1002/ehf2.12816

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7524237/
https://www.ncbi.nlm.nih.gov/pubmed/32578967
http://dx.doi.org/10.1002/ehf2.12816

Ejemplares similares